Navigation Links
Please don't wake me: one million people to be screened for risky sleep disorder
Date:3/15/2013

AMSTERDAM, March 15, 2013 /PRNewswire/ -- Snore much? Beware: it's one of the key signs of a disorder that may lead to serious chronic diseases, including diabetes or heart disease.

(Logo: http://photos.prnewswire.com/prnh/20110726/NY41282LOGO )

In an effort to help obstructive sleep apnea (OSA) sufferers identify and combat the disorder, Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today announced it will screen one million people worldwide for OSA over the next five years.

Philips' program, consistent with its stated commitment to improve access to health care and save lives, will include screening across North America, Europe and Asia. The program uses an online risk assessment on its World Sleep Day website. Individuals who have symptoms or believe they may be at-risk are encouraged to take the online risk assessment test. Upon completion, it will provide their risk level for OSA and encourage follow up with their health care provider.

"Obstructive sleep apnea steals health from its sufferers and put them on a path to potentially life-threatening diseases," said Brent Shafer , CEO, Philips Home Healthcare Solutions. "It is our goal to use our innovative solutions to help OSA sufferers identify and combat this very serious disorder."

Obstructive sleep apnea is one of the most common sleep disorders, and affects approximately five to six percent of the adult population1. It is characterized by a narrowing or closing of the upper airway, which hinders breathing during sleep.

Sleep is often labeled as the 'third pillar of good health', along with diet and exercise. Philips research suggests that more than two-thirds of all people with sleep apnea are not diagnosed.

The most common cause of obstructive sleep apnea is weight gain. Other signs and symptoms of sleep apnea include2:

  • Frequent loud snoring
  • Pauses in breathing or gasping for breath
  • Obesity
  • Regularly falling asleep in situations, such as reading, watching TV or driving
  • High blood pressure

"There are three important steps to helping individuals with OSA: awareness, diagnosis and treatment. Each is integral to improving the sleep quality and overall health of individuals around the world," said Dr. Lee-Chiong, chief medical liaison for Philips Home Healthcare Solutions. "Philips' pledge helps individuals take the first step to make them aware of their risk for OSA."

To find out if you're at risk for obstructive sleep apnea or for more information about World Sleep Day 2013 and what's happening in your local area, visit www.philips.com/worldsleepday.  

About Royal Philips Electronics

Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 118,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming, home and portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

1 Young T et al. (2002). Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med, 165, 1217-1239.

2 Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004 Apr 28;29:2013-6.


'/>"/>
SOURCE Philips
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Delcath Systems, Inc. Secures $20 Million Credit Facility
3. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
4. Arthrosurface Hits a $100 Million Milestone
5. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
6. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
7. Independa Closes Convertible Note Funding at $2.35 Million
8. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
9. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
10. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
11. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):